Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Crespo

Showing results (31-40 of 365) with videos related to

Pageof 37
Sort By:
Hepatobiliary Surgery and Nutrition|June 28, 2019
Paediatric non-alcoholic fatty liver disease: a more complex disease than in the adulthood?María Teresa Arias-Loste, Paula Iruzubieta, Javier Crespo
Revista Espanola De Enfermedades Digestivas|June 27, 2025
The liver as a thermometer of cardiometabolic health: time to prioritize MASLD in Global Health PolicyJavier Crespo, Paula Iruzubieta, Conrado M Fernández Rodríguez
Revista Espanola De Enfermedades Digestivas|September 5, 2024
Lights and shadows in the new definition of steatotic liver diseasePaula Iruzubieta, María Teresa Arias-Loste, Javier Crespo
Gastroenterologia Y Hepatologia|June 26, 2017
Resistance to hepatitis C virus. Implications and therapeutic optionsSusana Llerena, Joaquín Cabezas, Paula Iruzubieta, et al.
Hepatology (Baltimore, Md.)|May 18, 2023
Letter to the Editor: Updated guidance on NAFLD screeningMaría Teresa Arias-Loste, Javier Crespo, Paula Iruzubieta
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2015
Computerized Physician Order Entry-Based System Improves Hepatitis B Virus Screening in Patients Undergoing ChemotherapyJoaquín Cabezas, Blanca Sampedro, Cándido Hernández, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|August 7, 2019
In reply to: Confirmation of antibodies against hepatitis C virus by recombinant immunoblot: Is it really an improvement to abandon it?Federico García, Antonio Aguilera, Javier Crespo, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|September 26, 2013
[Telaprevir in treatment-naïve patients with HCV monoinfection]Joaquín Cabezas, Javier Crespo, Josefina Selmo, et al.
Revista Espanola De Enfermedades Digestivas|September 7, 2020
Relationship between gastroenterologists and hospital pharmacists: the results of a national survey. The CONDIFA studyFederico Argüelles Arias, Javier Crespo, Miguel Ángel Calleja Hernández
AIDS Reviews|March 19, 2016
NS5A Resistance: Clinical Implications and Treatment PossibilitiesJosé Luis Calleja, Susana Llerena, Christie Perelló, et al.
Pageof 37

Showing results (31-40 of 365) with videos related to

Sort By:
Pageof 37
Hepatobiliary Surgery and Nutrition|June 28, 2019
Paediatric non-alcoholic fatty liver disease: a more complex disease than in the adulthood?María Teresa Arias-Loste, Paula Iruzubieta, Javier Crespo
Revista Espanola De Enfermedades Digestivas|June 27, 2025
The liver as a thermometer of cardiometabolic health: time to prioritize MASLD in Global Health PolicyJavier Crespo, Paula Iruzubieta, Conrado M Fernández Rodríguez
Revista Espanola De Enfermedades Digestivas|September 5, 2024
Lights and shadows in the new definition of steatotic liver diseasePaula Iruzubieta, María Teresa Arias-Loste, Javier Crespo
Gastroenterologia Y Hepatologia|June 26, 2017
Resistance to hepatitis C virus. Implications and therapeutic optionsSusana Llerena, Joaquín Cabezas, Paula Iruzubieta, et al.
Hepatology (Baltimore, Md.)|May 18, 2023
Letter to the Editor: Updated guidance on NAFLD screeningMaría Teresa Arias-Loste, Javier Crespo, Paula Iruzubieta
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2015
Computerized Physician Order Entry-Based System Improves Hepatitis B Virus Screening in Patients Undergoing ChemotherapyJoaquín Cabezas, Blanca Sampedro, Cándido Hernández, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|August 7, 2019
In reply to: Confirmation of antibodies against hepatitis C virus by recombinant immunoblot: Is it really an improvement to abandon it?Federico García, Antonio Aguilera, Javier Crespo, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|September 26, 2013
[Telaprevir in treatment-naïve patients with HCV monoinfection]Joaquín Cabezas, Javier Crespo, Josefina Selmo, et al.
Revista Espanola De Enfermedades Digestivas|September 7, 2020
Relationship between gastroenterologists and hospital pharmacists: the results of a national survey. The CONDIFA studyFederico Argüelles Arias, Javier Crespo, Miguel Ángel Calleja Hernández
AIDS Reviews|March 19, 2016
NS5A Resistance: Clinical Implications and Treatment PossibilitiesJosé Luis Calleja, Susana Llerena, Christie Perelló, et al.
Pageof 37